Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TR 14035

Drug Profile

TR 14035

Alternative Names: SB 683698

Latest Information Update: 24 Jan 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Tanabe Seiyaku
  • Class Anti-inflammatories; Antiasthmatics; Antihyperglycaemics; Antirheumatics; Irritable bowel syndrome therapies
  • Mechanism of Action Alpha4beta7 integrin antagonists; Integrin alpha4beta1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Asthma; Irritable bowel syndrome; Multiple sclerosis; Rheumatoid arthritis

Most Recent Events

  • 24 Jan 2007 Removed [synonyms] from overview, which were already present in the synonyms list.
  • 25 Feb 2003 Discontinued - Phase-I for Irritable bowel syndrome in Europe (PO)
  • 25 Feb 2003 Discontinued - Phase-I for Irritable bowel syndrome in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top